Dow Up 0.51% Nasdaq Up 0.24%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
8.79 Down 0.19(2.12%) Nov 21, 4:00PM EST
Prev Close:8.98
Open:9.14
Bid:7.78 x 1000
Ask:N/A
1y Target Est:26.83
Beta:-1.94
Next Earnings Date:N/A
Day's Range:8.77 - 9.18
52wk Range:5.92 - 22.57
Volume:699,537
Avg Vol (3m):1,455,390
Market Cap:213.39M
P/E (ttm):N/A
EPS (ttm):-1.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RPRXDown 2.12%213.39M
ABTUp 0.07%65.97B
ACTUp 0.49%68.85B
AUXLUp 0.60%1.70B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.38
Quarterly EPS Est (Dec-14) :-0.31
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.30

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback